Citation: Stevenson AD, Mickan S, Mallett S, Ayya M. Systematic review of diagnostic accuracy of reflectance confocal microscopy for melanoma diagnosis in patients with clinically equivocal skin lesions. Dermatol Pract Conc. 2013;3(4): 5. http://dx.doi.org/10.5826/ dpc.0304a05. Background: Melanoma is a cancer of the skin and is increasing in incidence in the UK and Europe. Melanoma is a condition that is often curable if detected at an early stage, which makes accurate diagnosis vital. Reflectance confocal microscopy (RCM) is a tool used to image the skin. It gives high magnification images of the skin, which may provide more accurate diagnosis of lesions that are equivocal on clinical examination and dermoscopy. Objective: To determine the diagnostic accuracy of reflectance confocal microscopy (RCM), for melanoma diagnosis, as an add-on test to clinical examination and dermoscopy in the diagnosis of equivocal pigmented skin lesions using histopathology as the reference standard. Methods: A search was conducted of MEDLINE, EMBASE and six other electronic databases from inception to present. Forward citation searching and hand searching of reference lists were also conducted. Diagnostic accuracy studies that assess RCM in the diagnosis of melanoma were included in the review. Two contributors conducted the search, data extraction and assessment of methodological quality using QUADAS-2. Statistical analysis was performed using hierarchical bivariate random effects meta-analysis. Results: 951 titles and abstracts were screened. Five studies comprising 909 lesions were eligible for meta-analysis. Meta-analysis returned a per lesion sensitivity of 93% [95% CI 89-96] and a specificity of 76% [95% CI 68-83]. Conclusions: The utility of reflectance confocal microscopy (RCM) as an add-on test for the diagnosis of melanoma depends on the trade off between over-excising benign lesions and misdiagnosing melanoma as benign. This becomes important when considering lesions on surgically difficult or cosmetically important areas of the body.
Introduction
Melanoma is a cancer of the skin which is increasing in frequency both in the UK and Europe1. Cancer research UK (CRUK) have calculated that in the 35 years from 1975-2010 the age standardized incidence rate in the UK rose from 3.2 per 100000 to 17.2 per 1000002. The biggest risk factor for developing melanoma is exposure to ultraviolet light [3] .
Prognosis for melanoma is very much dependent on the stage of the disease when it is diagnosed so early accurate diagnosis of melanoma is crucial. The five-year survival for stage 1A melanoma is 97%. The five-year survival drops rapidly to 10-15% for stage 4 metastatic disease [4] . This rapid decline in survival with higher stage is because the only potentially curative treatment is surgical excision [5] . Adjuvant therapy for non-metastatic melanoma has not yet been demonstrated to provide a survival benefit [6] and no therapy has proven to extend survival for metastatic melanoma [7, 8] .
The currently accepted best diagnostic method for melanoma is dermoscopy [9] .
A recent meta-analysis of dermoscopy in the diagnosis of melanoma pooled the sensitivities and specificities and found a sensitivity of 91% and a specificity of 86% [10] . Most dermoscopy research has been conducted in white skinned populations however there is some evidence of the ability of dermoscopy to work equally well in non-white populations [11] .
Reflectance confocal microscopy (RCM) also known as confocal laser scanning microscopy (CLSM) of the skin was first described in the early 1990s [12] . This technology uses a near infrared laser to obtain images of the top layers of the skin. These images are magnified such that they are "quasi- images of RCM [13] . The test itself takes about ten minutes for imaging and evaluation of a skin lesion.
The goal of diagnosing melanoma is to correctly identify melanomas, while at the same time, excising as few benign lesions as possible. The most appropriate first line examination for this is dermoscopy, which has been shown to be a more accurate diagnostic tool than unaided eye examination [9] . Given the time needed to use RCM, it is most appropriate as a secondary examination add test to dermoscopy for lesions where dermoscopy does not give a confident diagnosis. This role has been suggested previously [14, 15] .
There have been many narrative reviews on the use of RCM in the diagnosis of melanoma. These articles have focused mainly on describing the technology and discussing its potential role in melanoma diagnosis. RCM technology has advanced since the first instruments were introduced in Review | Dermatol Pract Concept 2013;3(4):5
21

Assessment of methodological quality
Two authors independently assessed methodological quality of the studies using the QUADAS-2 tool [23] . Any disagreements were resolved by discussion. The results of the quality assessment are presented with a textural methodological quality summary and graphical representation.
Results
Search
The search of the databases was conducted on February 8, 2012 . After screening for duplicates 951 studies were examined. A flow diagram of the search can be found in Figure 1 .
After examining titles and abstracts the full text of 39 articles were retrieved. There were five articles that met the inclusion criteria. These are shown in Table 1 .
Excluded studies
There were five studies, which were derivation studies, or studies that did not validate on a new set of patients.
There were 15 descriptive correlation studies, which only described which RCM features were associated with melanoma. There were four case reports or small case series, two narrative review articles, one editorial and one study looking at observer agreement of the RCM features associated with melanoma.
Methodological quality assessment
The exclusion criteria for studies in the review included two major methodological quality criteria. The studies could not be case control studies nor could they be studies that set a diagnostic threshold i.e.: studies that developed a scoring system. Case control studies have been demonstrated to overestimate diagnostic accuracy when compared to cohort studies that use an appropriate spectrum [24] . Studies that derive/set a threshold use multivariable analysis to derive a score. These scores are derived on a certain population. It is very often the case that these scoring systems perform worse when they are validated in another population, however similar [25] .
This resulted in a low risk of bias regarding the applicability of the included patients and the appropriateness of the index test. In this study, the reporting of patient selection was generally poor however all domains were graded as low risk of bias. The methodological quality assessment is shown graphically in Table 2 .
Findings
Five studies were identified comprising 909 lesions. The average prevalence of melanoma was 36.2% with a range from 29-39. Three studies used the RCM diagnostic scor-
Type of study
Cohort studies of diagnostic test accuracy with a predefined threshold that was established on separate data are eligible for inclusion.
Target condition
Melanoma of the skin.
Study population
Patients presenting with lesions suspicious for melanoma that were equivocal to clinical and dermoscopic diagnosis. No restriction was placed upon participant characteristics such as age, sex, ethnicity etc.
Index test
Reflectance confocal microscopy. There was no restriction on the type of algorithm or diagnostic process.
Reference standard
Histopathology of the excised skin lesion or long-term clinical follow-up.
Data extraction and management
Per lesion data was extracted onto a study specific data 
Statistical analysis and data synthesis
Data were extracted by two reviewers independently. Hierarchical bivariate random-effects meta-analysis [19] was used to perform the statistical meta-analysis as this has been demonstrated to be the most robust method [19] .
If there appeared to be no or minimal threshold differences between the studies clinically or on the receiver operator characteristic (ROC) plot then a summary statistic in the form of sensitivity and specificity was planned [20] . If there were, clinically and visually, the appearance of a threshold effect then the summary ROC curve was planned as the most appropriate summary measure [20] .
If a study presented several sensitivity and specificity estimates on a receiver operator characteristic curve (ROC) then the point estimate used for meta-analysis was the point chosen by the author of the article.
The results are presented graphically using RevMan5 [21] . The studies were combined in a statistical meta-analysis using the METANDI function in STATA [22] .
Subgroup analyses was intended for investigation of operator experience and algorithm method however there was an insufficient number of studies.
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Per lesion sensitivity and specificity are shown on a forest plot in Figure 2 . There appears to be minimal heterogeneity per lesion in sensitivity across the studies, with more heterogeneity in the specificity. patient outcomes compared to the existing diagnostic pathway. It is not enough just to measure the sensitivity and specificity [28] .
Duff et al. [29] and Rampen et al. [30] followed patients after melanoma screening, searching for missed melanomas.
Duff found no missed melanomas from 1961 patients and Rampen found seven invasive melanomas and two lentigo maligna (a type of melanoma in situ) from 9968 patients seen in the clinic. This data suggests that, in real clinical contexts using current diagnostic technology, few melanomas are missed.
The purpose of this review was to evaluate RCM as an add-on test to existing diagnostic pathways, not to evaluate it as a replacement test. It has been suggested that RCM is more sensitive than dermoscopy [13] . If all lesions that were suspicious to the unaided eye examination were examined Given the low number of studies included in the review, statistical subgroup analysis and covariate hierarchical modeling for investigation of heterogeneity were not performed due to low statistical power.
Discussion
When examining the use of a new diagnostic test it is important to consider whether its introduction will improve with some monitoring procedure they may miss a melanoma.
To gauge the trade off between the reduction in unnecessary biopsies and the missed melanoma diagnoses the sensitivity and specificity can be applied to an estimated prevalence of melanoma in the spectrum of patients that would be selected for RCM examination.
The average prevalence of melanoma in the studies included in the review was 36%. In a 2002 systematic review of dermoscopy the mean frequency of melanoma was 28%.
Previous research has suggested a malignant to benign ration of 1:4 with the expert use of dermoscopy [32] . This translates These factors combined with the concept that diagnostic accuracy determined from laboratory condition studies may be different from the diagnostic accuracy in the real life clinical setting [31] , mean that the external validity of these results has to be taken cautiously. Pascale Guitera. In addition the small number of studies and poor reporting in the primary studies limited the scope of the review.
Summary
Reflectance confocal microscopy may contribute to the diagnosis of melanoma as an add-on test in the diagnostic pathway to reduce over-diagnosis following dermoscopy. Reduction in the excision rate of benign lesions that look suspicious on clinical examination may be important particularly where treatment by removal is potentially difficult or harmful. As no diagnostic test is 100% accurate, each clinician and patient will have to decide if the trade off between missing a small number of melanomas is worth the reduction in excision of benign lesions.
